bs-10149R [Primary Antibody]
ABCG8 Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: ABCG8

Immunogen Range: 566-673/673


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 64241

Swiss Prot: Q9H221

Source: KLH conjugated synthetic peptide derived from human ABCG8

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

Transporter that appears to play an indispensable role in the selective transport of the dietary cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)

Predicted Molecular Weight: 76


Cross Reactive Species: Human
Rat

Predicted Cross Reactive Species: Mouse
Dog
Cow
Pig
Horse
Rabbit

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Gao et al. Acute stress show great influences on liver function and the expression of hepatic genes associated with lipid metabolism in rats. (2013) Lipids.Health.Dis. 12:118Read more>>
  • Huang et al. Effects of mulberry leaf on experimental hyperlipidemia rats induced by high-fat diet. (2018) Exp.Ther.Med. 16:547-556Read more>>
  • Li R et al. Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1124-1133.Read more>>
  • Yu, Wen-Qian. et al. Polysaccharide CM1 from Cordyceps militaris hinders adipocyte differentiation and alleviates hyperlipidemia in LDLR(+/?) hamsters. Lipids Health Dis. 2021 Dec;20(1):1-17Read more>>
  • Huiming Hu. et al. The Hypolipidemic Effect of Hawthorn Leaf Flavonoids through Modulating Lipid Metabolism and Gut Microbiota in Hyperlipidemic Rats.. EVID-BASED COMPL ALT. 2022 Nov;2022:3033311-3033311Read more>>